文献速递白内障与屈光手术

对采用分段求和生物测量眼应用新型人工晶状体屈光度公式的前瞻性评估

Prospective Evaluation of a New IOL Power Formula in Eyes Measured By Sum-of-Segments Biometry.
PubMed 文献 · Am J Ophthalmol · 2025-06-19

这项前瞻性多中心生物测量准确性研究在523只白内障术后眼中计算Barrett True眼轴长度分段求和公式(BTAL-SOS)的预期残留屈光,并与Barrett Universal II分段求和公式(BUII-SOS)的潜在结果比较。全组平均预测误差BTAL-SOS为0.00±0.27 D,BUII-SOS为0.00±0.28 D(p=0.06)。在眼轴短于22.50 mm的73只眼中,BTAL-SOS统计学上优于BUII-SOS(p=0.03),平均预测误差为-0.05±0.31 D对0.07±0.36 D。

要点

  • 全组523只眼平均预测误差BTAL-SOS为0.00±0.27 D,BUII-SOS为0.00±0.28 D(p=0.06)。
  • 眼轴短于22.50 mm的73只眼中,BTAL-SOS平均预测误差-0.05±0.31 D,BUII-SOS为0.07±0.36 D(p=0.03)。
  • 眼轴长于24.50 mm的79只眼中,BTAL-SOS平均预测误差-0.02±0.24 D,BUII-SOS为-0.05±0.25 D(p=0.16)。

核心结论

  • BTAL-SOS公式在眼轴短于22.50 mm的眼中统计学上优于BUII-SOS(p=0.03)。

研究设计与样本

  • 前瞻性、多中心、多术者生物测量准确性研究,纳入523只白内障术后眼,所有眼最终视力≤0.20 LogMAR且散光≤0.75 D。

主要发现

  • 全组平均预测误差BTAL-SOS为0.00±0.27 D,BUII-SOS为0.00±0.28 D(p=0.06)。
  • 眼轴长于24.50 mm的79只眼中,平均预测误差BTAL-SOS为-0.02±0.24 D,BUII-SOS为-0.05±0.25 D(p=0.16)。
  • 眼轴短于22.50 mm的73只眼中,平均预测误差BTAL-SOS为-0.05±0.31 D,BUII-SOS为0.07±0.36 D(p=0.03)。
  • 预测误差≤0.50 D的比例:眼轴≤22.00 mm组BTAL-SOS为96.0%对BUII-SOS 84%;眼轴>22.00 mm且<22.50 mm组为87.50%对81.25%;眼轴22.50-24.50 mm组为92.45%对93.26%;眼轴>24.50 mm且<25.00 mm组为92.68%对92.68%;眼轴≥25.00 mm组为97.37%对94.74%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the clinical outcomes from cataract surgery in eyes measured with sum-of-segments (SOS) biometry using the new Barrett True Axial Length (BTAL-SOS) formula and compare the potential results with the Barrett Universal II (BUII-SOS) formula. DESIGN: Prospective, multi-site, multi-surgeon, biometry accuracy study. Four private practice locations in Lynwood, CA, Encino, CA, Olympia Fields, IL, and Albuquerque, NM, USA. METHODS: The expected residual refractions were calculated using the BTAL-SOS formula in 523 eyes after cataract surgery and compared to the potential results with the BUII-SOS formula. All eyes had a final visual acuity ≤0.20 LogMAR and ≤0.75 D of astigmatism. RESULTS: Mean prediction error (MPE) for the entire series was 0.00±0.27 D with BTAL-SOS compared to 0.00±0.28 D with BUII-SOS (p = 0.06). In 79 eyes longer than 24.50 mm, MPE was - 0.02±0.24 D with BTAL-SOS vs -0.05±0.25 D with BUII-SOS (p = 0.16) and in 73 eyes shorter than 22.50 mm, BTAL-SOS statistically outperformed BU II-SOS (p = 0.03) with a MPE of -0.05±0.31 D vs 0.07±0.36 D. BTAL-SOS prediction error (PE) ≤0.50 D was 96.0% vs 84% in short eyes (AL≤22.00mm), 87.50% vs 81.25% in medium short eyes (AL>22.00mm, <22.50mm), 92.45% vs 93.26% in average eyes (AL 22.50-24.50mm), 92.68% vs 92.68% in medium long eyes (AL>24.50mm, <25.00mm) and 97.37% vs 94.74% in long eyes (AL≥25.00mm) when compared to BUII-SOS results. CONCLUSION: BTAL-SOS formula performed statistically better (p = 0.03) than BUII-SOS in eyes shorter than 22.50 mm.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Shammas HJ, Shammas MC, Multack S, et al. Prospective Evaluation of a New IOL Power Formula in Eyes Measured By Sum-of-Segments Biometry. Am J Ophthalmol. 2025. PMID: 40543736. doi:10.1016/j.ajo.2025.06.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。